New EU Vaccine Research Network

CHIP participates in the new EU Vaccine Research Network VACCELERATE.
The European Union mobilises € 12 Mio. from Horizon 2020 to support the rapid establishment of a new EU-wide vaccine trial network. VACCELERATE will connect all European stakeholders involved in COVID-19 vaccine development and form the pan-European backbone accelerating phase 2 & 3 COVID-19 vaccine trials.
The kick-off meeting for the project VACCELERATE will take place on Friday the 5th of March 2021.
Find out more about VACCELARETE here.

Our mission

CHIP produces internationally recognised research aimed at people with affected immune systems on how best to improve their health and extend life.

Read more
Projects and Collaborations